eHealth, Inc. corrected earnings guidance for the full year ending December 31, 2022. The guidance for GAAP net loss for the full year ending December 31, 2022 in the section titled 2022 Guidance of the March 1, 2022 press release is corrected as set forth below: --GAAP net loss for the full year ending December 31, 2022 is expected to be in the range of $106.0 million to $83.0 million, corrected from a range of $147.0 million to $124.0 million. Total revenue is expected to be in the range of $448.0 million to $470.0 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.52 USD | -0.66% | +4.15% | -48.17% |
Apr. 18 | EHealth Reaffirms 2024 Guidance | MT |
Apr. 15 | Adherium’s Hailie Smartinhaler Secures FDA Approval for Use with AstraZeneca's Airsupra and Breztri Inhalation Devices | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-48.17% | 131M | |
+6.12% | 61.29B | |
+5.31% | 51.7B | |
+9.65% | 27.05B | |
+15.50% | 23.44B | |
+23.57% | 9.27B | |
+18.04% | 6.03B | |
-2.58% | 4.06B | |
+3.75% | 2.03B | |
+13.70% | 1.77B |
- Stock Market
- Equities
- EHTH Stock
- News eHealth, Inc.
- Ehealth, Inc. Corrects Earnings Guidance for the Full Year Ending December 31, 2022